bf/NASDAQ:BLFS_icon.jpeg

NASDAQ:BLFS

BioLife Solutions Inc.

  • Stock

USD

Last Close

23.03

26/07 20:00

Market Cap

1.11B

Beta: 1.84

Volume Today

334.29K

Avg: 296.26K

PE Ratio

−7.53

PFCF: −47.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Jan '15
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
538.66K
-
693.07K
28.67%
1.40M
101.99%
1.80M
28.31%
1.80M
0.34%
2.68M
48.57%
7.32M
173.15%
11.36M
55.32%
19.97M
75.80%
31.62M
58.33%
39.18M
23.89%
average payables
864.78K
-
670.87K
22.42%
752.02K
12.10%
870.05K
15.69%
700.71K
19.46%
705.35K
0.66%
1.92M
172.13%
3.40M
76.90%
9.31M
174.14%
15.16M
62.82%
11.15M
26.41%
average receivables
804.73K
-
955.47K
18.73%
915.46K
4.19%
1.06M
15.95%
1.11M
4.33%
2.03M
83.58%
4.20M
106.33%
6.68M
59.13%
15.61M
133.86%
28.58M
83.05%
26.30M
7.98%
book value per share
-2.65
-
1.33
150.34%
0.70
47.62%
0.25
64.16%
0.76
203.84%
2.65
248.84%
4.27
60.74%
7.52
76.18%
12.49
66.11%
-5.81
146.55%
0.01
100.13%
capex per share
-0.05
-
-0.06
19.44%
-0.12
106.26%
-0.10
14.59%
-0.01
89.10%
-0.03
183.77%
-0.03
12.77%
-0.17
389.15%
-0.22
28.35%
-0.24
12.26%
-0.00
99.94%
capex to depreciation
-0.96
-
-2.28
138.49%
-4.13
80.81%
-3.42
17.32%
-0.42
87.57%
-1.48
248.49%
-0.38
74.61%
-0.91
143.37%
-0.65
28.70%
-0.63
3.27%
-0.52
17.68%
capex to operating cash flow
-1.62
-
0.19
111.50%
0.29
52.85%
0.29
1.94%
-0.24
181.79%
-0.21
10.39%
-0.56
161.32%
-0.71
27.79%
1.73
343.82%
1.22
29.44%
0.51
58.27%
capex to revenue
-0.03
-
-0.10
260.19%
-0.22
130.79%
-0.15
30.49%
-0.01
91.46%
-0.03
94.17%
-0.02
2.63%
-0.10
290.68%
-0.07
26.96%
-0.06
8.77%
-0.04
30.63%
cash per share
0.03
-
1.66
5,218.48%
0.45
72.90%
0.11
75.27%
0.50
351.71%
1.89
275.41%
0.33
82.43%
3.31
899.77%
1.81
45.22%
1.48
18.66%
0.00
99.92%
days of inventory on hand
29.62
-
111.66
276.93%
254.16
127.63%
186.10
26.78%
157.66
15.28%
206.01
30.67%
458.25
122.44%
205.11
55.24%
127.09
38.04%
118.03
7.13%
209.39
77.40%
days payables outstanding
61.02
-
54.91
10.02%
142.60
159.71%
75.24
47.24%
58.96
21.63%
42.27
28.30%
128.52
204.04%
64.92
49.49%
67.01
3.22%
51.97
22.45%
33.44
35.65%
days sales outstanding
41.16
-
53.16
29.14%
52.60
1.06%
52.96
0.69%
33.82
36.13%
56.30
66.46%
71.28
26.61%
60.77
14.74%
71.12
17.03%
76.57
7.67%
47.53
37.93%
debt to assets
3.16
-
0.36
-
0.01
-
0.05
226.25%
0.05
2.41%
0.10
99.61%
0.10
6.54%
debt to equity
-0.80
-
0.90
-
0.02
-
0.05
233.21%
0.06
2.89%
-0.18
416.64%
0.13
171.42%
dividend yield
0.00
-
0.00
66.99%
earnings yield
-0.03
-
-0.17
575.21%
-0.16
8.36%
-0.34
111.76%
-0.03
90.64%
0.02
152.85%
0.04
110.37%
0.00
93.03%
-0.01
338.58%
-0.18
2,995.43%
-0.00
99.95%
enterprise value
52.51M
-
8.55M
83.71%
22.60M
164.24%
21.80M
3.55%
72.92M
234.55%
164.91M
126.15%
309.77M
87.85%
1.01B
226.03%
1.39B
37.83%
797.43M
42.72%
710.44B
88,992.19%
enterprise value over ebitda
-553.54
-
-2.73
99.51%
-4.50
65.15%
-10.56
134.32%
-69.05
554.20%
45.03
165.21%
304.90
577.06%
-339.36
211.30%
-58.04
82.90%
-27.02
53.45%
-10.03K
37,025.00%
ev to operating cash flow
359.67
-
-2.70
100.75%
-4.54
68.00%
-5.04
10.86%
120.53
2,492.69%
70.23
41.73%
255.38
263.61%
155.02
39.30%
-287.85
285.69%
-93.94
67.37%
-56.84K
60,413.97%
ev to sales
5.87
-
1.38
76.46%
3.50
153.66%
2.65
24.40%
6.62
149.71%
8.35
26.26%
11.32
35.49%
21.00
85.57%
11.68
44.38%
4.93
57.80%
4.96K
100,488.84%
free cash flow per share
-0.02
-
-0.36
1,883.83%
-0.52
46.14%
-0.44
15.85%
0.03
107.87%
0.11
226.91%
0.03
75.68%
0.07
149.30%
-0.34
598.20%
-0.44
29.39%
-0.00
99.90%
free cash flow yield
-0.00
-
-0.20
9,314.77%
-0.24
19.21%
-0.27
13.40%
0.01
102.11%
0.01
63.05%
0.00
81.92%
0.00
1.12%
-0.01
633.22%
-0.02
164.97%
-0.00
99.89%
graham net net
-3.10
-
1.57
150.59%
0.38
75.98%
-0.13
133.24%
0.48
479.97%
1.99
319.21%
0.31
84.44%
2.66
758.65%
0.77
71.11%
0.46
40.09%
0.00
99.94%
graham number
3.59
-
3.04
15.37%
2.33
23.29%
1.75
24.95%
1.80
2.93%
3.46
92.26%
7.39
113.26%
4.06
44.98%
7.82
92.43%
20.75
165.27%
0.02
99.92%
income quality
-0.13
-
0.96
811.39%
1.00
3.93%
0.54
45.96%
-0.24
144.70%
0.72
398.87%
-0.73
201.83%
2.44
433.70%
0.63
74.07%
0.06
90.41%
0.19
209.86%
intangibles to total assets
0
-
0.14
Infinity%
0.32
129.57%
0
100%
0
0
0.60
Infinity%
0.38
36.27%
0.68
78.95%
0.57
16.36%
0.60
4.44%
interest coverage
-0.38
-
-17.68
4,499.90%
-230.64
1,204.16%
-48.51
78.97%
-5.56
88.55%
732.40
13,282.44%
-156.20
121.33%
70.29
-
-58.10
182.65%
39.09
167.28%
interest debt per share
2.27
-
0.02
99.25%
0.00
89.47%
0.23
12,935.37%
0.01
93.85%
0.00
97.85%
0.07
22,605.24%
0.41
484.87%
0.69
68.17%
1.05
52.17%
0.00
99.91%
inventory turnover
12.32
-
3.27
73.47%
1.44
56.07%
1.96
36.57%
2.32
18.04%
1.77
23.47%
0.80
55.04%
1.78
123.41%
2.87
61.39%
3.09
7.67%
1.74
43.63%
invested capital
-0.80
-
0.90
-
0.02
-
0.05
233.21%
0.06
2.89%
-0.18
416.64%
0.13
171.42%
market cap
42.07M
-
18.49M
56.04%
26.42M
42.91%
20.36M
22.96%
79.58M
290.90%
195.57M
145.73%
314.87M
61.00%
1.09B
245.94%
1.44B
31.75%
773.15M
46.12%
710.44B
91,788.05%
net current asset value
-14.75M
-
10.03M
168.01%
4.46M
55.50%
-133K
102.98%
7.88M
6,024.81%
35.24M
347.27%
14.19M
59.73%
85.13M
499.84%
54.01M
36.56%
52.41M
2.95%
45.55M
13.09%
net debt to ebitda
-110.12
-
3.17
102.88%
0.76
75.95%
-0.70
191.35%
6.31
1,006.08%
-8.37
232.68%
-5.01
40.11%
26.65
631.49%
1.79
93.27%
-0.82
145.88%
-0.10
87.49%
net income per share
-0.22
-
-0.31
42.28%
-0.35
12.35%
-0.54
57.14%
-0.19
65.13%
0.20
205.96%
0.57
182.94%
0.10
82.82%
-0.22
322.91%
-3.29
1,411.59%
-0.00
99.95%
operating cash flow per share
0.03
-
-0.30
1,138.25%
-0.41
34.94%
-0.34
16.21%
0.05
113.33%
0.14
216.66%
0.06
56.84%
0.24
282.77%
-0.13
152.64%
-0.20
59.10%
-0.00
99.86%
payables turnover
5.98
-
6.65
11.13%
2.56
61.50%
4.85
89.54%
6.19
27.61%
8.63
39.48%
2.84
67.11%
5.62
97.98%
5.45
3.12%
7.02
28.95%
10.92
55.40%
receivables turnover
8.87
-
6.87
22.56%
6.94
1.07%
6.89
0.68%
10.79
56.58%
6.48
39.92%
5.12
21.02%
6.01
17.29%
5.13
14.55%
4.77
7.13%
7.68
61.10%
research and ddevelopement to revenue
0.05
-
0.14
158.15%
0.21
51.95%
0.25
15.35%
0.11
56.11%
0.07
39.26%
0.15
128.94%
0.14
7.16%
0.10
29.02%
0.09
7.77%
0.13
43.41%
return on tangible assets
-0.32
-
-0.23
28.18%
-0.50
114.63%
-0.87
74.03%
-0.21
76.12%
0.07
134.68%
0.30
311.85%
0.02
93.80%
-0.05
359.97%
-0.72
1,415.21%
-0.40
45.20%
revenue per share
1.79
-
0.59
66.84%
0.53
10.63%
0.65
22.87%
0.83
27.70%
1.21
46.14%
1.41
15.82%
1.76
25.21%
3.09
75.73%
3.81
23.04%
0.00
99.91%
roe
0.08
-
-0.23
382.64%
-0.50
114.50%
-2.17
338.46%
-0.25
88.52%
0.08
130.37%
0.13
76.02%
0.01
90.25%
-0.02
234.19%
0.57
3,347.10%
-0.20
134.57%
roic
0.19
-
-0.22
217.93%
-0.49
124.75%
-0.97
97.02%
-0.17
82.95%
0.07
145.10%
-0.01
114.19%
0.07
721.52%
-0.02
125.58%
0.21
1,336.97%
-0.18
185.29%
sales general and administrative to revenue
0.30
-
0.64
111.09%
0.75
17.72%
0.56
26.07%
0.41
26.48%
0.30
26.56%
0.33
10.05%
0.30
8.41%
0.29
5.80%
0.29
2.99%
0.39
31.98%
shareholders equity per share
-2.65
-
1.33
150.34%
0.70
47.62%
0.25
64.16%
0.76
203.84%
2.65
248.84%
4.27
60.74%
7.52
76.18%
12.49
66.11%
-5.81
146.55%
0.01
100.13%
stock based compensation to revenue
0.03
-
0.04
33.77%
0.08
113.77%
0.09
19.08%
0.12
22.02%
0.08
33.23%
0.11
44.49%
0.12
11.88%
0.12
5.83%
0.16
33.72%
0.22
41.14%
tangible asset value
-13.27M
-
11.72M
188.32%
5.95M
49.28%
3.17M
46.75%
10.09M
218.76%
43.15M
327.55%
27.41M
36.48%
115.75M
322.33%
103.86M
10.27%
107.36M
3.37%
91.77M
14.52%
tangible book value per share
-2.65
-
1.12
142.34%
0.49
56.48%
0.25
48.71%
0.76
203.84%
2.65
248.84%
1.41
46.94%
4.24
200.98%
2.70
36.37%
2.53
6.31%
0.00
99.92%
working capital
250.12K
-
10.90M
4,259.54%
5.25M
51.88%
3.50M
33.39%
8.42M
140.86%
35.63M
323.20%
16.40M
53.96%
99.14M
504.43%
85.89M
13.37%
93.87M
9.29%
78.43M
16.45%

All numbers in USD (except ratios and percentages)